Locations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2018
Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits. The company leverages insights from human genetics to identify the molecular basis of diseases, aiming to improve the success rate of clinical trials. With a cross-disciplinary team that includes experts in genetics, drug discovery, and ethics, Variant Bio prioritizes ethical research practices and benefit-sharing with partner communities. Their innovative approach positions them at the forefront of genomic drug discovery, addressing significant unmet medical needs in the healthcare market.
Something looks off?